MedPath

A comparison of sedative effect with dexmedetomidine -fentanyl versus midazolaml–fentanyl during cataract surgery with phacoemulsification technique

Phase 2
Conditions
Cataract surgery.
Cataract in diseases classified elsewhere
Registration Number
IRCT20180416039326N3
Lead Sponsor
Esfahan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
70
Inclusion Criteria

patients aged 18–85 years old ASA class 1 & 2 scheduled for phacoemulsification cataract surgery

Exclusion Criteria

refusing, mentally challenged patients , history of chronic use of sedatives, narcotics or alcohol , allergy to any of the study medications , patients with severe chronic obstructive pulmonary disease, Asthma,, history of cardiac disease (cardiac block and bradycardia) bradycardia (heart rate less than 50 beats per minute), systolic blood pressure less than 90 mm, Severe hepatic failure, uncontrolled diabetes, left ventricular failure (EF less than 30), and cerebrovascular disease,severe renal failures

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Sedation level. Timepoint: Every 5 minutes during surgery. Method of measurement: Ramsay sedation score.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath